Trustmark National Bank Trust Department Has $2.37 Million Stock Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Trustmark National Bank Trust Department boosted its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 17.9% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 5,819 shares of the company’s stock after purchasing an additional 883 shares during the quarter. Trustmark National Bank Trust Department’s holdings in HCA Healthcare were worth $2,365,000 at the end of the most recent reporting period.

Several other hedge funds also recently made changes to their positions in HCA. Capital World Investors grew its holdings in shares of HCA Healthcare by 57.5% during the 1st quarter. Capital World Investors now owns 2,792,377 shares of the company’s stock worth $931,342,000 after purchasing an additional 1,019,750 shares in the last quarter. Darsana Capital Partners LP increased its stake in HCA Healthcare by 53.3% in the second quarter. Darsana Capital Partners LP now owns 1,150,000 shares of the company’s stock valued at $369,472,000 after acquiring an additional 400,000 shares during the last quarter. TD Asset Management Inc lifted its holdings in shares of HCA Healthcare by 2.7% in the second quarter. TD Asset Management Inc now owns 741,130 shares of the company’s stock worth $238,110,000 after acquiring an additional 19,812 shares during the last quarter. Epoch Investment Partners Inc. grew its stake in shares of HCA Healthcare by 16.4% during the second quarter. Epoch Investment Partners Inc. now owns 631,854 shares of the company’s stock worth $203,002,000 after buying an additional 88,948 shares during the last quarter. Finally, National Pension Service boosted its holdings in shares of HCA Healthcare by 11.9% during the 3rd quarter. National Pension Service now owns 550,654 shares of the company’s stock valued at $223,802,000 after acquiring an additional 58,353 shares in the last quarter. 62.73% of the stock is owned by institutional investors.

Insider Activity at HCA Healthcare

In other news, EVP Michael S. Cuffe sold 8,358 shares of HCA Healthcare stock in a transaction on Thursday, September 12th. The stock was sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the sale, the executive vice president now directly owns 29,678 shares in the company, valued at $11,438,494.76. The trade was a 21.97 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, SVP Phillip G. Billington sold 3,897 shares of the firm’s stock in a transaction dated Thursday, November 14th. The stock was sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the sale, the senior vice president now owns 52,702 shares of the company’s stock, valued at $18,445,700. This trade represents a 6.89 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 15,155 shares of company stock valued at $5,608,990. 1.60% of the stock is owned by insiders.

HCA Healthcare Stock Performance

Shares of HCA stock opened at $333.00 on Thursday. The firm has a market capitalization of $84.35 billion, a PE ratio of 14.95, a price-to-earnings-growth ratio of 1.29 and a beta of 1.68. The firm has a fifty day simple moving average of $381.99 and a two-hundred day simple moving average of $358.12. HCA Healthcare, Inc. has a 12 month low of $245.84 and a 12 month high of $417.14. The company has a current ratio of 1.12, a quick ratio of 1.00 and a debt-to-equity ratio of 48.71.

HCA Healthcare Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Friday, December 13th will be paid a $0.66 dividend. This represents a $2.64 annualized dividend and a dividend yield of 0.79%. The ex-dividend date is Friday, December 13th. HCA Healthcare’s dividend payout ratio (DPR) is presently 11.85%.

Wall Street Analysts Forecast Growth

A number of brokerages have recently commented on HCA. Wolfe Research raised HCA Healthcare to a “strong-buy” rating in a research note on Thursday, August 29th. Royal Bank of Canada raised their price target on shares of HCA Healthcare from $378.00 to $405.00 and gave the company an “outperform” rating in a research note on Friday, August 23rd. Leerink Partners raised their target price on HCA Healthcare from $367.00 to $396.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 24th. Wells Fargo & Company raised their price objective on HCA Healthcare from $395.00 to $400.00 and gave the stock an “equal weight” rating in a research report on Wednesday, November 6th. Finally, Oppenheimer boosted their price target on shares of HCA Healthcare from $390.00 to $400.00 and gave the stock an “outperform” rating in a research report on Monday, October 28th. Five investment analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat.com, HCA Healthcare has a consensus rating of “Moderate Buy” and an average price target of $385.00.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.